This Week in Cardiology

An elegant study in post-TAVI atrioventricular block, a PSA for my structural colleagues, ... more

Less is more after PCI, the TARGET-FIRST trial, a negative blood pressure trial that is ac... more

Listener feedback, huge news in the world of carotid disease with the CREST-2 publication,... more

Listener feedback on the PISCES trial, AHA news (including a big PCSK9i trial), beta-block... more

Listener feedback on non-culprit PCI in STEMI, a major cardiac result in patients on hemod... more

Four pillars of cardiology today, stable coronary artery disease, severe aortic stenosis, ... more

The PREVENT score in hypertension, GLP-1 mechanism of action in cardiovascular disease, CA... more

Another knock against the antiplatelet/anticoagulant combo, polypills in HF, the physical ... more

GLP-1 use in HFrEF, left atrial posterior wall isolation during AF ablation, peri-device l... more

Two great stories of translation science leading to beneficial drugs in terrible diseases ... more

A bold trial in valvular heart disease, a CV prevention trial whose message is humility, V... more

More trials at ESC, including PARACHUTE HF, DAPA ACT HF-TIMI 68, AMALFI, and a super-inter... more

More from ESC including: Valvular HD guidelines, a new drug class for HTN, myosin inhibiti... more

The big beta-blocker story from ESC, dual pathway therapy with aspirin and OAC, stopping O... more

CAC 0 takes a gut punch, ICD therapies cannot be surrogates for benefit, and two important... more

John Mandrola discusses conduction system pacing vs standard pacing, withdrawing HF meds w... more

Big new hypertension guidelines, ultraprocessed foods, coronary sinus reduction and eviden... more

Listener feedback on SURPASS CVOT, AF ablation and the limits of meta-analyses, a Watchman... more

Exercise and CV outcomes, aldosterone modulation, AI for ECG reading, GLP-1 comparisons, e... more

The VENTOUX study of endurance athletes, the 10,000 step myth was not busted, rate vs rhyt... more

Finerenone, what not to consider when choosing treatment of AS, brain health after atrial ... more

Approval of first-generation devices, the ticagrelor controversy, ICD longevity, the PRAGU... more

FDA approves triple-drug polypill, a change of opinion, a deep dive into invasive pulmonar... more

A big, deep dive into CTA and fractional flow reserve CT, and a sobering report on the new... more

Listener feedback on cardiac sarcoidosis, SA node ablation, surgical AF ablation, chronic ... more